KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo

KOBAYASHI PHARMACEUTICAL CO.,LTD.

Develops, manufactures, and markets OTC pharmaceuticals, health, and household goods.

4967 | T

Overview

Corporate Details

ISIN(s):
JP3301100008
LEI:
Country:
Japan
Address:
大阪市中央区道修町4丁目4番10号

Description

Kobayashi Pharmaceutical Co., Ltd. is a company engaged in the development, manufacturing, and marketing of a wide range of consumer products. Its core business segments include over-the-counter (OTC) pharmaceuticals, health and personal care items, and household goods. The company's diverse product portfolio features items such as nutritional supplements, deodorizing air fresheners, and disposable body warmers. Kobayashi Pharmaceutical focuses on creating innovative and niche products designed to solve specific, everyday problems for consumers, reflecting its brand slogan, 'You make a wish and we make it happen'.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 08:30
確認書
Japanese 8.1 KB
2025-08-08 08:30
半期報告書-第108期(2025/01/01-2025/12/31)
Japanese 226.4 KB
2025-03-31 08:27
臨時報告書
Japanese 25.4 KB
2025-03-28 07:33
確認書
Japanese 8.2 KB
2025-03-28 07:32
内部統制報告書-第107期(2024/01/01-2024/12/31)
Japanese 22.2 KB
2025-03-28 07:32
有価証券報告書-第107期(2024/01/01-2024/12/31)
Japanese 2.1 MB
2025-02-20 08:51
臨時報告書
Japanese 25.1 KB
2025-02-10 07:32
訂正臨時報告書
Japanese 24.5 KB
2025-01-21 09:01
臨時報告書
Japanese 20.7 KB
2024-12-26 05:03
臨時報告書
Japanese 20.5 KB
2024-11-08 07:41
訂正臨時報告書
Japanese 24.1 KB
2024-08-09 08:00
確認書
Japanese 8.1 KB
2024-08-09 08:00
半期報告書-第107期(2024/01/01-2024/12/31)
Japanese 240.4 KB
2024-08-08 08:30
訂正臨時報告書
Japanese 24.0 KB
2024-07-23 08:29
臨時報告書
Japanese 20.9 KB

Automate Your Workflow. Get a real-time feed of all KOBAYASHI PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOBAYASHI PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOBAYASHI PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bioversys N Logo
Clinical-stage biopharma developing antibacterial therapies for antimicrobial resistance.
Switzerland
BIOV
BIOVIE INC. Logo
Develops drug therapies for neurological disorders and advanced liver disease.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
Biopharmaceutical company using AI to develop drugs for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology therapies targeting families of oncogenic mutations.
United States of America
BDTX
BL Pharmtech Corp. Logo
Researches, develops, and sells health foods, supplements, and pharmaceuticals.
South Korea
065170
BNC Korea Co, Ltd Logo
Develops hyaluronic acid-based dermal fillers and botulinum toxin injectables.
South Korea
256840
Boditech Med Inc. Logo
Develops, manufactures, and distributes in-vitro diagnostic (IVD) solutions.
South Korea
206640
BOIRON Logo
A family-owned pharmaceutical laboratory and a world leader in homeopathic medicines.
France
BOI
Manufactures specialty ingredients for the food, pharmaceutical, and cosmetic industries.
South Korea
002760
Bolt Biotherapeutics, Inc. Logo
Clinical-stage biotech developing immuno-oncology therapies using the innate immune system.
United States of America
BOLT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.